The PPARG Pro12Ala polymorphism is associated with a decreased risk of developing hyperglycemia over 6 years and combines with the effect of the APM1 G-11391A single nucleotide polymorphism: the Data From an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) study. [electronic resource]
- Diabetes Apr 2006
- 1157-62 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't